Northwestern University
Chicago, United States
Dr. Sonabend is a brain tumor neurosurgeon/scientist, who specializes in the care of patients with malignant and benign brain tumors. He is a tenured Associate Professor of Neurosurgery, and the Director of Translational Neuro-Oncology at Northwestern University Feinberg School of Medicine. He discovered predictive biomarkers for immunotherapy in glioblastoma. He described the use of stem cells for delivery of virotherapy for gliomas, and systems for chronic intra-cerebral drug delivery, concepts currently undergoing clinical testing. He is implementing the use ultrasounds to deliver drugs across the BBB in investigator-initiated trials. He leads a translational brain tumor lab that has been continuously funded by the NIH since 2015.